BioSpace News Archive

Veeva Systems announced that leaders from Boehringer Ingelheim, GSK, and UCB will be among the featured keynote speakers at the 2021 Veeva Commercial & Medical North America Summit Connect on June 10, 2021.

Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, announced management will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 10:30 AM E.T.

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced that the full line of OrbusNeich® JADE® percutaneous transluminal angioplasty over-the-wire balloon catheters is now available in the U.S.

Cybin Inc., a biotechnology company focused on progressing psychedelic therapeutics, announced the sponsorship of Kernel’s feasibility study of its Kernel Flow technology to measure Ketamine’s psychedelic effect on cerebral cortex hemodynamics.

Veracyte, Inc. announced it has reached the terms of an agreement to acquire HalioDx in a transaction to further accelerate growth and strengthen Veracyte’s global leadership in cancer diagnostics.

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for respiratory disease, allergy and opioid overdose, today provided the following business update.